 Comparative efficacy daptomycin vancomycin cloxacillin treatment Staphylococcus endocarditis rats role test conditions determination vivo efficacy daptomycin new cell wall-active anti-gram-positive-bacterial agent cloxacillin vancomycin rat model Staphylococcus aureus endocarditis methicillin-susceptible aureus MSSA methicillin-resistant aureus MRSA strains therapy infection time valvular bacterial counts low CFU/g vegetation days therapy effective MSSA antibiotic regimen contrast onset therapy infection bacterial counts valves CFU/g vegetation period treatment days infection conditions days therapy daptomycin effective cloxacillin vancomycin MSSA strains daptomycin activity vancomycin MRSA strain days treatment days antibiotics effective doses daptomycin decreasing activity mg/kg body weight mg/kg mg/kg drug levels blood detectable first infection vitro daptomycin high concentrations micrograms/ml levels serum doses mg/kg bacteriostatic concentrations micrograms/ml trough levels serum